OCULISA
With Oculisa, salespeople focus on more valuable leads and close more deals. Install it to your website within 3 minutes, get deep analytics for each lead, enrich your data, and empower sales with predictive lead scoring by Oculisa’s AI. Let Oculisa become the eyes of your sales department. Oculisa helps to find out the probability of a successful deal before a salesperson ever even contacts a potential client. For eCommerce users, Lisa will recommend cross-sell and upsell products to each new lead. As a result, the salesperson can drive more profit. Built with a focus on SMB's needs, Oculisa also features an easy-to-use sales funnel page, simple pricing that fits any business, and automatic data transfer.
OCULISA
Social Links:
Industry:
Analytics E-Commerce Information Services Information Technology Machine Learning Marketing Software
Founded:
2018-12-08
Address:
Kyiv, Kyyiv, Ukraine
Country:
Ukraine
Website Url:
http://www.oculisa.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network
Official Site Inspections
http://www.oculisa.com Semrush global rank: 5.41 M Semrush visits lastest month: 1.56 K
- Host name: a67c48129651a0940.awsglobalaccelerator.com
- IP address: 13.248.213.45
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Oculisa"
Oculisa - Crunchbase Company Profile & Funding
With Oculisa, salespeople focus on more valuable leads and close more deals. Install it to your website within 3 minutes, get deep analytics for each lead, enrich your data, and empower …See details»
Meet Our Team - Oculis
We are a global biopharmaceutical company purposefully driven to save sight and improve eye care. Led by an experienced management team and supported by leading investors and …See details»
Oculis Holding - Overview, News & Similar companies - ZoomInfo
Aug 12, 2024 Who is Oculis Holding. Headquartered in Zug, Switzerland with global operations in Europe, the U.S. and China. Oculis is a biopharmaceutical company focused on developing …See details»
Oculis - Crunchbase Company Profile & Funding
The Oculis drug delivery platform allows diseases such as DME (diabetic macular edema) at the posterior part of the eye to be treated with a non-invasive …See details»
Oculis | SEC Filing
Oculis Holding AG (Translation of registrant’s name into English) Bahnhofstrasse 7. CH-6300. Zug, Switzerland (Address of registrant’s principal executive office) ... Article 24 Function, …See details»
About Us - Ophthalmology Companies - Oculis
Since then, the Oculis team has built and consistently advanced the company’s highly differentiated pipeline including multiple product candidates which have the potential to transform eye care and improve vision for patients worldwide. …See details»
Oculis | Corporate Governance
The Board of Directors of Oculis Holding AG (the “Company”) sets high standards for our employees, officers and directors. Implicit in this philosophy is the importance of sound …See details»
Oculis Holding AG - EQT Group
Nov 22, 2024 oculis.com. Sector. Healthcare. Country. Switzerland. Fund. LSP 7. Entry. 2022. Web. oculis.com. Latest news. 29 November 2024 EQT Exeter completes Spanish student …See details»
SEC Filing - Oculis
Unless otherwise stated or unless the context otherwise requires, references to “New Parent” or the “Company” are to the registrant named “Oculis Holding AG”, previously a direct subsidiary …See details»
Oculis Operations Sàrl – Swiss Biotech
Oculis is a biopharmaceutical company purposefully driven to save sight & improve eye care. Oculis’ highly differentiated pipeline comprises multiple innovative product candidates in …See details»
Oculis Announces an Oversubscribed US$57 million Series C …
LAUSANNE, Switzerland, May 04, 2021 (GLOBE NEWSWIRE) -- Oculis S.A., (Oculis) a late-stage biopharmaceutical company focused on developing transformative ophthalmic …See details»
Oculis - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Oculis . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... including Chief Medical Officer & Co-Founder Einar …See details»
Oculis | Investors and Media
Oculis is a global biopharmaceutical company (Nasdaq: OCS; XICE: OCS) purposefully driven to save sight and improve eye care. Oculis’ highly differentiated pipeline comprises multiple …See details»
Oculis Reports Q3 2024 Financial Results and Provides Company …
Nov 7, 2024 Merger and listing expense, which was a one-time non-cash expense CHF 34.9 million or $38.2 million in total operating expenses in the nine months ended September 30, …See details»
Oculis Company Profile - Office Locations, Competitors, Revenue …
Oculis is a biopharmaceutical company focused on eye care. Its products include OCS-01, a topical retinal candidate for diabetic macular edema, OCS-02, a topical biologic candidate for …See details»
Oculis - Your Local General Contractor and Handyman
Enhance the security and organization of your event or construction site with our top-notch Fence Rentals. We offer a diverse range of fencing options, from Temporary Fence Panels and Post …See details»
SEC Filing - Oculis
United states. securities and exchange commission. washington, d.c. 20549. form 20-f (mark one) ☐ registration statement pursuant to section 12(b) or 12(g) of the securities exchange act of …See details»
Oculis Labs - Crunchbase Company Profile & Funding
Organization. Oculis Labs . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Oculis Labs is a security company providing …See details»
OneSight EssilorLuxottica Foundation Joins Forces with World …
2 days ago OneSight EssilorLuxottica Foundation Joins Forces with World Health Organization to Advance Global Vision Care Under WHO SPECS 2030 Initiative Provided by …See details»
Rethinking Ophthalmology - Oculis
Aug 8, 2023 Oculis announces positive top line results from DIAMOND Stage 1 phase 3 trial in diabetic macular edema with OCS-01 eye drops. .May 22, 2023. 3. Shulman S, et al. Acta …See details»